eConsent

eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future for clinical trials here.

eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for clinical trials.

Castor is using video conferencing to meet participant needs and lower site burden in clinical trials. Find 5 benefits here.

If you are planning on using eConsent in a trial, you’ll need to include it in your IRB submission. Find out what to include here.

Informed consent is a critical aspect of clinical trials. But what criteria must be met? And is there more than one type of consent? Find out here.

The future of informed consent is digital. Learn about the benefits, the process, the regulatory landscape, and the future of eConsent here.

Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing…

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…